Sickness Funds and the Pharmaceutical Industry: a New Relationship?Beapp_Bcpm
On Friday 3rd March, Dr Jan Van Emelen, Innovation Director at Neutral Mutualities presented on “Mutualities and pharmaceutical industry: a new relationship?”. Access to new, often very expensive medications is a hot topic and our speaker discussed the role of the mutualities in this process, using new models for disease management. He shared ideas on our potential interaction with this process as pharmaceutical physicians.
Sickness Funds and the Pharmaceutical Industry: a New Relationship?Beapp_Bcpm
On Friday 3rd March, Dr Jan Van Emelen, Innovation Director at Neutral Mutualities presented on “Mutualities and pharmaceutical industry: a new relationship?”. Access to new, often very expensive medications is a hot topic and our speaker discussed the role of the mutualities in this process, using new models for disease management. He shared ideas on our potential interaction with this process as pharmaceutical physicians.
Razones por las que las empresas adoptan la nube - evento Cloud de Microsoft ...SOFTENG
En esta presentación, Carlos Colell e Imma Rasero Director General y Socia Directora de Softeng, hablaron sobre las razones por las que las empresas adoptan la nube y el valor que aporta realmente el Cloud a las empresas
Razones por las que las empresas adoptan la nube - evento Cloud de Microsoft ...SOFTENG
En esta presentación, Carlos Colell e Imma Rasero Director General y Socia Directora de Softeng, hablaron sobre las razones por las que las empresas adoptan la nube y el valor que aporta realmente el Cloud a las empresas